Metastatic Breast Cancer News from 2021 ESMO
The European Society for Medical Oncology (ESMO) was held virtually from September 16-21, 2021. Links to MBC-related news from this conference are found below....
Read MoreTheragnostics
The term “theragnostics” (also called “theranostics”) is a combination of two words: therapy and diagnostics. This technology allows...
Read MoreSpotlight on the Tigerlily Foundation & Breast Cancer Racial Disparities
Our newest Metastatic Trial Search partner is the Tigerlily Foundation. Tigerlily educates, advocates for, empowers, and supports young women diagnosed with...
Read MoreHealth Insurance for MBC
A cancer diagnosis is a life-changing event. It not only impacts health, it can also affect every aspect of one’s life, including finances, insurance,...
Read MoreAtezolizumab Immunotherapy Is Withdrawn From FDA-Approval Process
Atezolizumab (Tecentriq®) was the first FDA-approved immunotherapy for treating locally advanced or metastatic triple-negative breast cancer (TNBC). It is for...
Read MoreMetastatic Trial Search: New Features
Metastatic Trial Search provides clinical trial information in a patient-friendly format that makes it easy to understand what a trial is studying, who can...
Read MoreMetastatic Breast Cancer News from ASCO 2021
The American Society of Clinical Oncology’s (ASCO) annual meeting was held online from June 4 through June 8, 2021. During the conference, researchers...
Read MoreFDA Fast Track
FDA Fast Track is a program to accelerate the development, review, and approval of new drugs to fill an unmet medical need, such as treatment for metastatic...
Read MoreAdoptive Cell Therapies: A Type of Immunotherapy for MBC
Immunotherapy is a type of treatment that increases the immune system’s ability to kill cancer cells. Many immunotherapy treatments are drugs. However,...
Read MoreSEARCH OUR SITE
for past articles or specific information.